GLP-1 injection sites: where to inject Ozempic, Wegovy, Mounjaro and Zepbound, and how to rotate

Where can you inject a GLP-1?

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are once-weekly injections given under the skin, into fatty tissue, not into muscle or a vein. Every current US label lists the same three body areas: the abdomen, the thigh and the upper arm. The details differ by product and device, so your own pen’s Instructions for Use (IFU) always wins.

Medicine	Approved sites (US label)	Upper arm
Ozempic (semaglutide)	Abdomen, thigh, upper arm	Listed in the label; the prefilled-syringe IFU says back of the arm only with help
Wegovy (semaglutide)	Abdomen, thigh, upper arm	Listed for the single-dose pen; the prefilled-syringe IFU says only with help
Mounjaro (tirzepatide)	Abdomen, thigh, back of upper arm	Another person should give the injection
Zepbound (tirzepatide)	Abdomen, thigh, back of upper arm	Another person should give the injection

A few practical rules show up across the instructions:

• Stay away from the belly button. Several IFUs (Wegovy single-dose pen, Mounjaro and Zepbound KwikPen, semaglutide prefilled syringes) say at least 2 inches (5 cm) from it.
• Pick healthy skin. Skip areas that are tender, bruised, red, scaly or hard, and avoid scars, stretch marks, pits, thickened skin and lumps.
• Front of the thigh is the usual thigh zone; Wegovy’s pen IFU describes it as the upper leg, front of the thighs.
• Struggling to inject? Wegovy’s IFU suggests a firmer site such as the thigh or upper arm, or standing up when injecting into the lower abdomen.

Does the injection site affect absorption?

For the two main GLP-1 molecules, the labels answer this directly. The Ozempic, Wegovy, Mounjaro and Zepbound prescribing information all state that exposure was similar whether the drug was injected into the abdomen, thigh or upper arm.

The tirzepatide data are public. In a crossover study (NCT04050670), 54 healthy adults with lower and higher BMI received a single 5 mg dose in each site.

In other words, there is no need to hunt for a “best” site to get more medicine. Choose the spot you can reach comfortably and inject correctly. The thing that seems to matter more is the condition of the skin you inject into.

Why rotate GLP-1 injection sites?

Repeated injections into the same small patch of skin can cause lipohypertrophy: rubbery, thickened lumps of fatty tissue. The international FITTER injection-technique recommendations (Frid et al., 2016) describe it as a frequent complication that distorts absorption, advise against injecting into it and say correct rotation helps prevent it.

Most of the evidence comes from insulin, which people often inject several times a day:

• In a study of 430 insulin users, 64.4% had lipohypertrophy. Only 5% of people who rotated correctly had it, while 98% of those with it rotated incorrectly or not at all. Reusing needles more than five times also raised the risk (Blanco et al., 2013).
• When insulin was injected into lipohypertrophic tissue, absorption was lower and far more variable than from normal tissue (Famulla et al., 2016).

A weekly GLP-1 means far fewer injections, and data specific to GLP-1s are limited. Still, the labels take rotation seriously: Mounjaro’s vial instructions say rotating within an area lowers the risk of lipodystrophy (pits or thickened skin) and localized cutaneous amyloidosis (lumps).

How do you rotate GLP-1 injection sites?

The labels keep it simple: use a different spot every week. You may stay in the same body area, as long as the exact spot changes. Injection-technique guidance adds two habits (FIT India 2.0, Tandon et al., 2015):

• Rotate within a site: keep each new injection at least 1 cm (roughly a finger’s width) from the previous one.
• Rotate between sites: split the abdomen into quadrants and the thighs or arms into halves, and move to a new zone in a fixed direction.

A simple 4-zone weekly plan

1. Week 1: abdomen, left side (2+ inches from the belly button)
2. Week 2: abdomen, right side
3. Week 3: left thigh, front
4. Week 4: right thigh, front
5. Week 5: back to the left abdomen, at least 1 cm from your week 1 spot

If someone can help you, add the back of each upper arm as zones 5 and 6, so every spot gets even longer to recover. If you also inject insulin, the Ozempic label says the two can go in the same body region but not right next to each other, and never mixed.

How do you inject a GLP-1 pen correctly?

Pens differ, so treat this as a checklist to compare with your own IFU, not a replacement for it.

• Check the medicine. Semaglutide should look clear and colorless; tirzepatide clear and colorless to slightly yellow. Don’t use it if you see particles or discoloration.
• Clean and dry. Wipe the spot with an alcohol swab and let it dry.
• Hold for the full time. The Ozempic pen IFU says to keep the button pressed and count 6 seconds after the counter shows 0. The Mounjaro and Zepbound single-dose pens say press and hold up to 10 seconds, until the second click. The Wegovy single-dose pen says keep pressing until the yellow bar stops. Lifting early can mean a missed part of the dose.
• Needles. For multi-dose pens like Ozempic, use a new needle every time, and never share a pen, even with a new needle.
• Bleeding. Press lightly with gauze or cotton; don’t rub.

For keeping pens in good condition between doses, see our GLP-1 pen storage and travel guide. If you’re just starting, our first-month guide covers what else to expect.

How common are injection-site reactions on GLP-1s?

The US labels report injection-site reactions such as redness, itching, bruising, pain or rash:

• Ozempic: 0.2% in placebo-controlled trials
• Wegovy: 1.4% vs 1% on placebo
• Mounjaro: 3.2% vs 0.4% on placebo
• Zepbound: 6–8% across doses vs 2% on placebo

These come from different trials with different definitions, so they aren’t a head-to-head comparison. For tirzepatide, reactions were more common in people who developed antibodies to the drug (11.3% vs 1% in the Zepbound weight-loss trials).

When should you see a doctor about an injection-site reaction?

Contact your care team, without changing or skipping a dose on your own, if you notice:

• Skin around the site that becomes hot, swollen and increasingly painful, especially with feeling unwell or a fever (possible infection)
• A reaction that keeps coming back or doesn’t fade
• Lumps, pits or thickened skin where you usually inject

Get emergency help for signs of a serious allergic reaction: swelling of the face, lips, tongue or throat; trouble breathing or swallowing; severe rash or itching; fainting or dizziness; or a very rapid heartbeat. The Mounjaro Medication Guide says to stop using the medicine and get medical help right away in that case.

Make rotation automatic

With a week between shots, it’s easy to forget where the last one went. GLPMate’s GLP-1 shot tracker logs each dose with reminders and shows an injection-site rotation map, so you can see last week’s spot before choosing this week’s. If a reaction shows up, you can note it with a severity in the side-effect log and bring the history to your next appointment.

This article is educational only and not medical advice. Ask your doctor, nurse or pharmacist to show you the technique that fits your pen.

FAQ

FAQ

Where is the best place to inject Ozempic or Wegovy?

The US labels allow the abdomen, the thigh and the upper arm, and they report similar semaglutide exposure from all three. So the best place is the one you can reach comfortably on healthy skin, at least 2 inches from the belly button if you use the abdomen. Rotate to a new spot every week and follow the instructions for your specific pen.

Does injection site affect how much Mounjaro or Zepbound you absorb?

Not by much, based on the data available. The tirzepatide labels say exposure is similar across the abdomen, thigh and upper arm, and a 54-person crossover study found total exposure from the thigh about 5% lower and from the upper arm about 1% lower than from the abdomen. That study measured drug levels, not weight loss or blood sugar.

Can I inject my GLP-1 in the same spot every week?

No. Every label says to rotate, and you can stay in the same area as long as you choose a different spot. Injection-technique guidance suggests keeping each new injection at least 1 cm away from the last one. Repeated injections into one spot are linked to rubbery lumps (lipohypertrophy), mostly studied in insulin users.

Is a red, itchy spot after a GLP-1 shot normal?

Injection-site reactions such as redness, itching or bruising are listed side effects; in the US labels they ranged from 0.2% (Ozempic) to 6–8% (Zepbound) of trial participants. Tell your care team if the area becomes hot, swollen or increasingly painful, or if you get a fever. Swelling of the face or throat, trouble breathing or fainting needs emergency care.